Evidence map›Paper›PMID 27089515›Full record

ArticleNature medicine2016

Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice.

Vivian M Choi, Julien Herrou, Aaron L Hecht, Wei Ping Teoh, Jerrold R Turner, Sean Crosson, Juliane Bubeck Wardenburg

Abstract read
In one paragraph

Article in Nature medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Outer membrane vesicles secreted byInfection and immunity · 2026
    Article
  5. Orally available designed miniproteins inhibit enterotoxigenicbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Lessons from the model gut BacteroidalesJournal of bacteriology · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vivian M ChoiDepartment of Microbiology, University of Chicago, Chicago, Illinois, USA.
Julien HerrouDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USA.
Aaron L HechtDepartment of Microbiology, University of Chicago, Chicago, Illinois, USA.
Wei Ping TeohDepartment of Microbiology, University of Chicago, Chicago, Illinois, USA.
Jerrold R TurnerDepartment of Pathology, University of Chicago, Chicago, Illinois, USA.
Sean CrossonDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USA.
Juliane Bubeck WardenburgDepartment of Microbiology, University of Chicago, Chicago, Illinois, USA.
University of Chicago · US

Funding

MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI CHANG, EUGENE B · 1990 to 2025
$29.8M
ZO-1-MEDIATED PROTEIN INTERACTIONS: REGULATORS AND INTEGRATORS OF DIVERSE EPITHELIAL FUNCTIONS IN HEALTH AND DISEASER01DK061931 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2001 to 2026
$15.0M
Therapeutic targeting of protein interactions to reverse MLCK1-mediated intestinal barrier loss and ameliorate disease.R01DK068271 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2005 to 2026
$11.3M
Transcriptional Regulation of NHE-3 Isoform in Human IntestineP01DK067887 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HECHT, GAIL A · 2006 to 2011
$4.9M
HTS ASSAYS FOR INHIBITORS OF PROTEIN INTERACTIONS INCLUDING MLCK1-FKBP8R56DK094954 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MILLER, LAWRENCE, TURNER, JERROLD R. · 2012 to 2012
$157k
NIDDK NIH HHS P01 DK067887NIDDK NIH HHS P30 DK042086NIDDK NIH HHS R01 DK061931NIDDK NIH HHS R01 DK068271NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

Bacteroides fragilis is the leading cause of anaerobic bacteremia and sepsis. Enterotoxigenic strains that produce B. fragilis toxin (BFT, fragilysin) contribute to colitis and intestinal malignancy, yet are also isolated in bloodstream infection. It is not known whether these strains harbor unique genetic determinants that confer virulence in extra-intestinal disease. We demonstrate that BFT contributes to sepsis in mice, and we identify a B. fragilis protease called fragipain (Fpn) that is required for the endogenous activation of BFT through the removal of its auto-inhibitory prodomain. Structural analysis of Fpn reveals a His-Cys catalytic dyad that is characteristic of C11-family cysteine proteases that are conserved in multiple pathogenic Bacteroides spp. and Clostridium spp. Fpn-deficient, enterotoxigenic B. fragilis has an attenuated ability to induce sepsis in mice; however, Fpn is dispensable in B. fragilis colitis, wherein host proteases mediate BFT activation. Our findings define a role for B. fragilis enterotoxin and its activating protease in the pathogenesis of bloodstream infection, which indicates a greater complexity of cellular targeting and activity of BFT than previously recognized. The expression of fpn by both toxigenic and nontoxigenic strains suggests that this protease may contribute to anaerobic sepsis in ways that extend beyond its role in toxin activation. It could thus potentially serve as a target for disease modification.

Indexed as

AnimalsBacteremiaBacteria, AnaerobicBacterial ProteinsBacterial ToxinsBacteroides fragilisBacteroides InfectionsBlotting, WesternColitisCrystallography, X-RayCysteine ProteasesFluorescent Antibody TechniqueMetalloendopeptidasesMiceSepsisVirulenceBacterial ProteinsBacterial ToxinsBacteroides fragilis toxinCysteine ProteasesfragilysinMetalloendopeptidases

Identifiers

PMID27089515
PMCPMC4860040
OpenAlexW2336585584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.